Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-11-13

Clinical Trial Update: THE EFFECTS OF MIRABEGRON AND TAMSULOSIN FOR PATIENTS WITH URETERAL STENTS [Phase 4]

View source ↗

Summary

A Phase 4 trial update evaluating the effects of mirabegron and tamsulosin in patients with ureteral stents for ureteral and kidney stones.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Mirabegron (mirabegron)
  • Tamsulosin (tamsulosin)

Snippet

Sponsor: Hasanuddin University | Conditions: Ureteral Stone, Kidney Stones | Phase 4 | Status: COMPLETED